U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549607) titled 'Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting' on March 12.

Brief Summary: The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.

Study Start Date: April 01

Study Type: OBSERVATIONAL

Condition: Primary Bilary Cirrhosis (PBC)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: University of Leipzig

Information provided by (Responsible Party): Johannes Wiegand, University of Leipzig

Published by HT Digital Content Services with permission from Health Dai...